Greater BP reductions with olmesartan than candesartan

Gespeichert in:

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2003

Schlagwörter:	Candesartan Ambulatory Blood Pressure Monitoring Olmesartan Candesartan Cilexetil Olmesartan Medoxomil

Anmerkung:	© Adis International Ltd 2003

Übergeordnetes Werk:	Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 1400(2003), 1 vom: Aug., Seite 16-16
Übergeordnetes Werk:	volume:1400 ; year:2003 ; number:1 ; month:08 ; pages:16-16

Links:	Volltext

DOI / URN:	10.2165/00128413-200314000-00042

Katalog-ID:	SPR03516400X

Internformat


LEADER	01000caa a22002652 4500
001	SPR03516400X
003	DE-627
005	20230519204056.0
007	cr uuu---uuuuu
008	201007s2003 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.2165/00128413-200314000-00042 \|2 doi
035			\|a (DE-627)SPR03516400X
035			\|a (SPR)00128413-200314000-00042-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a Greater BP reductions with olmesartan than candesartan
264		1	\|c 2003
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Adis International Ltd 2003
650		4	\|a Candesartan \|7 (dpeaa)DE-He213
650		4	\|a Ambulatory Blood Pressure Monitoring \|7 (dpeaa)DE-He213
650		4	\|a Olmesartan \|7 (dpeaa)DE-He213
650		4	\|a Candesartan Cilexetil \|7 (dpeaa)DE-He213
650		4	\|a Olmesartan Medoxomil \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t Inpharma weekly \|d Auckland : ADIS internat., 1975 \|g 1400(2003), 1 vom: Aug., Seite 16-16 \|w (DE-627)373977859 \|w (DE-600)2127607-9 \|x 2230-6056 \|7 nnns
773	1	8	\|g volume:1400 \|g year:2003 \|g number:1 \|g month:08 \|g pages:16-16
856	4	0	\|u https://dx.doi.org/10.2165/00128413-200314000-00042 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
951			\|a AR
952			\|d 1400 \|j 2003 \|e 1 \|c 08 \|h 16-16

Indexfelder

matchkey_str	article:22306056:2003----::raebrdcinwtomsrata
hierarchy_sort_str	2003
publishDate	2003
allfields	10.2165/00128413-200314000-00042 doi (DE-627)SPR03516400X (SPR)00128413-200314000-00042-e DE-627 ger DE-627 rakwb eng Greater BP reductions with olmesartan than candesartan 2003 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2003 Candesartan (dpeaa)DE-He213 Ambulatory Blood Pressure Monitoring (dpeaa)DE-He213 Olmesartan (dpeaa)DE-He213 Candesartan Cilexetil (dpeaa)DE-He213 Olmesartan Medoxomil (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1400(2003), 1 vom: Aug., Seite 16-16 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1400 year:2003 number:1 month:08 pages:16-16 https://dx.doi.org/10.2165/00128413-200314000-00042 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1400 2003 1 08 16-16
spelling	10.2165/00128413-200314000-00042 doi (DE-627)SPR03516400X (SPR)00128413-200314000-00042-e DE-627 ger DE-627 rakwb eng Greater BP reductions with olmesartan than candesartan 2003 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2003 Candesartan (dpeaa)DE-He213 Ambulatory Blood Pressure Monitoring (dpeaa)DE-He213 Olmesartan (dpeaa)DE-He213 Candesartan Cilexetil (dpeaa)DE-He213 Olmesartan Medoxomil (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1400(2003), 1 vom: Aug., Seite 16-16 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1400 year:2003 number:1 month:08 pages:16-16 https://dx.doi.org/10.2165/00128413-200314000-00042 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1400 2003 1 08 16-16
allfields_unstemmed	10.2165/00128413-200314000-00042 doi (DE-627)SPR03516400X (SPR)00128413-200314000-00042-e DE-627 ger DE-627 rakwb eng Greater BP reductions with olmesartan than candesartan 2003 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2003 Candesartan (dpeaa)DE-He213 Ambulatory Blood Pressure Monitoring (dpeaa)DE-He213 Olmesartan (dpeaa)DE-He213 Candesartan Cilexetil (dpeaa)DE-He213 Olmesartan Medoxomil (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1400(2003), 1 vom: Aug., Seite 16-16 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1400 year:2003 number:1 month:08 pages:16-16 https://dx.doi.org/10.2165/00128413-200314000-00042 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1400 2003 1 08 16-16
allfieldsGer	10.2165/00128413-200314000-00042 doi (DE-627)SPR03516400X (SPR)00128413-200314000-00042-e DE-627 ger DE-627 rakwb eng Greater BP reductions with olmesartan than candesartan 2003 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2003 Candesartan (dpeaa)DE-He213 Ambulatory Blood Pressure Monitoring (dpeaa)DE-He213 Olmesartan (dpeaa)DE-He213 Candesartan Cilexetil (dpeaa)DE-He213 Olmesartan Medoxomil (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1400(2003), 1 vom: Aug., Seite 16-16 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1400 year:2003 number:1 month:08 pages:16-16 https://dx.doi.org/10.2165/00128413-200314000-00042 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1400 2003 1 08 16-16
allfieldsSound	10.2165/00128413-200314000-00042 doi (DE-627)SPR03516400X (SPR)00128413-200314000-00042-e DE-627 ger DE-627 rakwb eng Greater BP reductions with olmesartan than candesartan 2003 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2003 Candesartan (dpeaa)DE-He213 Ambulatory Blood Pressure Monitoring (dpeaa)DE-He213 Olmesartan (dpeaa)DE-He213 Candesartan Cilexetil (dpeaa)DE-He213 Olmesartan Medoxomil (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1400(2003), 1 vom: Aug., Seite 16-16 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1400 year:2003 number:1 month:08 pages:16-16 https://dx.doi.org/10.2165/00128413-200314000-00042 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1400 2003 1 08 16-16
language	English
source	Enthalten in Inpharma weekly 1400(2003), 1 vom: Aug., Seite 16-16 volume:1400 year:2003 number:1 month:08 pages:16-16
sourceStr	Enthalten in Inpharma weekly 1400(2003), 1 vom: Aug., Seite 16-16 volume:1400 year:2003 number:1 month:08 pages:16-16
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Candesartan Ambulatory Blood Pressure Monitoring Olmesartan Candesartan Cilexetil Olmesartan Medoxomil
isfreeaccess_bool	false
container_title	Inpharma weekly
publishDateDaySort_date	2003-08-01T00:00:00Z
hierarchy_top_id	373977859
id	SPR03516400X
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR03516400X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519204056.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2003 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200314000-00042</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR03516400X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200314000-00042-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Greater BP reductions with olmesartan than candesartan</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2003</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2003</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Candesartan</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ambulatory Blood Pressure Monitoring</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Olmesartan</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Candesartan Cilexetil</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Olmesartan Medoxomil</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1400(2003), 1 vom: Aug., Seite 16-16</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1400</subfield><subfield code="g">year:2003</subfield><subfield code="g">number:1</subfield><subfield code="g">month:08</subfield><subfield code="g">pages:16-16</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200314000-00042</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1400</subfield><subfield code="j">2003</subfield><subfield code="e">1</subfield><subfield code="c">08</subfield><subfield code="h">16-16</subfield></datafield></record></collection>
ppnlink_with_tag_str_mv	@@773@@(DE-627)373977859
format	electronic Article
delete_txt_mv	keep
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2230-6056
topic_title	Greater BP reductions with olmesartan than candesartan Candesartan (dpeaa)DE-He213 Ambulatory Blood Pressure Monitoring (dpeaa)DE-He213 Olmesartan (dpeaa)DE-He213 Candesartan Cilexetil (dpeaa)DE-He213 Olmesartan Medoxomil (dpeaa)DE-He213
topic	misc Candesartan misc Ambulatory Blood Pressure Monitoring misc Olmesartan misc Candesartan Cilexetil misc Olmesartan Medoxomil
spellingShingle	misc Candesartan misc Ambulatory Blood Pressure Monitoring misc Olmesartan misc Candesartan Cilexetil misc Olmesartan Medoxomil Greater BP reductions with olmesartan than candesartan
topic_unstemmed	misc Candesartan misc Ambulatory Blood Pressure Monitoring misc Olmesartan misc Candesartan Cilexetil misc Olmesartan Medoxomil
topic_browse	misc Candesartan misc Ambulatory Blood Pressure Monitoring misc Olmesartan misc Candesartan Cilexetil misc Olmesartan Medoxomil
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Inpharma weekly
hierarchy_parent_id	373977859
hierarchy_top_title	Inpharma weekly
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)373977859 (DE-600)2127607-9
title	Greater BP reductions with olmesartan than candesartan
ctrlnum	(DE-627)SPR03516400X (SPR)00128413-200314000-00042-e
title_full	Greater BP reductions with olmesartan than candesartan
journal	Inpharma weekly
journalStr	Inpharma weekly
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	2003
contenttype_str_mv	txt
container_start_page	16
container_volume	1400
format_se	Elektronische Aufsätze
doi_str_mv	10.2165/00128413-200314000-00042
title_sort	greater bp reductions with olmesartan than candesartan
title_auth	Greater BP reductions with olmesartan than candesartan
abstract	© Adis International Ltd 2003
abstractGer	© Adis International Ltd 2003
abstract_unstemmed	© Adis International Ltd 2003
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20
container_issue	1
title_short	Greater BP reductions with olmesartan than candesartan
url	https://dx.doi.org/10.2165/00128413-200314000-00042
remote_bool	true
ppnlink	373977859
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.2165/00128413-200314000-00042
up_date	2024-07-03T13:46:45.077Z
_version_	1803565824819068928
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR03516400X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519204056.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2003 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200314000-00042</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR03516400X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200314000-00042-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Greater BP reductions with olmesartan than candesartan</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2003</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2003</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Candesartan</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ambulatory Blood Pressure Monitoring</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Olmesartan</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Candesartan Cilexetil</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Olmesartan Medoxomil</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1400(2003), 1 vom: Aug., Seite 16-16</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1400</subfield><subfield code="g">year:2003</subfield><subfield code="g">number:1</subfield><subfield code="g">month:08</subfield><subfield code="g">pages:16-16</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200314000-00042</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1400</subfield><subfield code="j">2003</subfield><subfield code="e">1</subfield><subfield code="c">08</subfield><subfield code="h">16-16</subfield></datafield></record></collection>
score	7.399934

Nicht das Richtige dabei?

Schreiben Sie uns!

Greater BP reductions with olmesartan than candesartan

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?